NCT00710385 - Abuse Liability of Suboxone Versus Subutex | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Opioid-related Disorders

Interventions

DRUG

Heroin

Heroin (25 mg)

DRUG

Naloxone

.4 mg

DRUG

Low Bup Dose

4 and 8 mg

DRUG

High Bup Dose

8mg and 16 mg

DRUG

Low Bup/Nal Dose

Buprenorphine/Naloxone 4/1 mg, 8/2 mg

DRUG

High Bup/Nal Dose

Buprenorphine/Naloxone 8/2 mg, 16/4 mg

DRUG

Placebo (PCB)

Placebo control administration

Trial Locations (1)

New York State Psychiatric Institute/Columbia University, New York